financetom
Business
financetom
/
Business
/
Update: Oceanic Iron Ore Edges Up After Appointing Former CFO Batalha as CEO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Oceanic Iron Ore Edges Up After Appointing Former CFO Batalha as CEO
Aug 23, 2024 1:02 PM

10:51 AM EDT, 08/23/2024 (MT Newswires) -- Oceanic Iron Ore ( FEOVF ) overnight Thursday said it named Chris Batalha as chief executive and executive director, succeeding Bing Pan who had served as interim CEO.

Batalha returns to the company after serving as chief financial officer and corporate secretary from 2014 through 2022.

Previously, Batalha has held executive positions at Artemis Gold and Atlantic Gold.

The company's share price at last look rose 6.3% to $0.085 in early Friday trading.

Price: 0.09, Change: +0.01, Percent Change: +6.25

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Recliners, rumbles, and reboots: Theaters bet big on movie magic
Recliners, rumbles, and reboots: Theaters bet big on movie magic
Sep 17, 2025
* Theater chains invest $1.5 billion in upgrades * Enhanced formats account for 14.9% of ticket sales * Premium experiences offset 23% decline in ticket sales By Harshita Mary Varghese and Dawn Chmielewski Sept 17 (Reuters) - With a $5 million makeover, Phoenix Theatres transformed a 10-screen cinema at Cleveland's Great Northern Mall into a cinematic escape where wall-to-wall screens,...
GSK Plans $30 Billion US Investment Over 5 Years
GSK Plans $30 Billion US Investment Over 5 Years
Sep 17, 2025
05:59 AM EDT, 09/17/2025 (MT Newswires) -- GSK (GSK) said Wednesday it plans to invest $30 billion in the US over the next five years to expand research and development and strengthen its supply chain infrastructure. The company said its plan includes a $1.2 billion investment in advanced biopharma manufacturing and lab facilities, as well as expanding AI and digital...
Oruka Therapeutics Says ORKA-001 Interim Early-Stage Data Supports Extended Dosing Intervals; Plans $180 Million Private Placement
Oruka Therapeutics Says ORKA-001 Interim Early-Stage Data Supports Extended Dosing Intervals; Plans $180 Million Private Placement
Sep 17, 2025
06:16 AM EDT, 09/17/2025 (MT Newswires) -- Oruka Therapeutics ( ORKA ) said Wednesday that interim data from an early-stage trial of its long-acting antibody ORKA-001 showed a half-life of about 100 days, which could increase the likelihood of dosing once annually in plaque psoriasis. The company said pharmacokinetic data indicated exposures that could support higher efficacy and extended off-treatment...
Novo Nordisk's Alzheimer's trial a 'lottery ticket', senior executive says
Novo Nordisk's Alzheimer's trial a 'lottery ticket', senior executive says
Sep 17, 2025
COPENHAGEN, Sept 17 (Reuters) - A senior Novo Nordisk executive on Wednesday described the drugmaker's ongoing trial of its blockbuster obesity medicine for treatment of Alzheimer's disease as a lottery ticket due to its uncertain prospects yet huge potential. The Danish drugmaker expects data from its pivotal Alzheimer's disease trial by the end of 2025. After blockbuster success in weight...
Copyright 2023-2026 - www.financetom.com All Rights Reserved